Foldit

The highest scoring solutions are analyzed by researchers, who determine whether or not there is a native structural configuration (native state) that can be applied to relevant proteins in the real world. Scientists can then use these solutions to target and eradicate diseases and create biological innovations. A 2010 paper in the science journal Nature credited Foldit's 57,000 players with providing useful results that matched or outperformed algorithmically computed solutions.

• Name — Foldit • Developer — University of Washington, Center for Game Science, Department of Biochemistry • Latest Preview Version — Perpetual beta • Operating System — Cross-platform: Windows, macOS, Linux • Size — ≈434 MB • Language — Czech, Dutch, English, French, German, Hebrew, Indonesian, Italian, Polish, Romanian, Russian, Spanish, Scientist • Language Count — 13 • Genre — Puzzle video game, protein folding • License — Proprietary freeware for academic and non-profit use • Website — https: fold.it

Prof. David Baker, a protein research scientist at the University of Washington, founded the Foldit project. Seth Cooper was the lead game designer. Before starting the project, Baker and his laboratory coworkers relied on another research project named Rosetta to predict the native structures of various proteins using special computer protein structure prediction algorithms. Rosetta was eventually extended to use the power of distributed computing: The Rosetta@home program was made available for public download, and displayed its protein-folding progress as a screensaver. Its results were sent to a central server for verification. Some Rosetta@home users became frustrated when they saw ways to solve protein structures, but could not interact with the program. Hoping that humans could improve the computers' attempts to solve protein structures, Baker approached David Salesin and Zoran Popović, computer science professors at the same university, to help conceptualize and build an interactive program - a video game - that would appeal to the public and help efforts to find native protein structures.

Many of the same people who created Rosetta@home worked on Foldit. The public beta version was released in May 2008 and has 240,000 registered players. Since 2008, Foldit has participated in Critical Assessment of Techniques for Protein Structure Prediction (CASP) experiments, submitting its best solutions to targets based on unknown protein structures. CASP is an international program to assess methods of protein structure prediction and identify those that are most productive.

Protein structure prediction is important in several fields of science, including bioinformatics, molecular biology, and medicine. Identifying natural proteins' structural configurations enables scientists to understand them better. This can lead to creating novel proteins by design, advances in treating disease, and solutions for other real-world problems such as invasive species, waste, and pollution. The process by which living beings create the primary structure of proteins, protein biosynthesis, is reasonably well understood, as is the means by which proteins are encoded as DNA. However, determining how a given protein's primary structure becomes a functioning three-dimensional structure, how the molecule folds, is more difficult. The general process is understood, but predicting a protein's eventual, functioning structure is computationally demanding.

Foldit attempts to apply the human brain's three-dimensional pattern matching and spatial reasoning abilities to help solve the problem of protein structure prediction. 2016 puzzles are based on well-understood proteins. By analysing how humans intuitively approach these puzzles, researchers hope to improve the algorithms used by protein-folding software. Foldit includes a series of tutorials where users manipulate simple protein-like structures and a periodically updated set of puzzles based on real proteins. It shows a graphical representation of each protein which users can manipulate using a set of tools.

Foldit's developers wanted to attract as many people as possible to the cause of protein folding. So, rather than only building a useful science tool, they used gamification (the inclusion of gaming elements) to make Foldit appealing and engaging to the general public. As a protein structure is modified, a score is calculated based on how well-folded the protein is, and a list of high scores for each puzzle is maintained. Foldit users may create and join groups, and members of groups can share puzzle solutions. Groups have been found to be useful in training new players. A separate list of group high scores is maintained, as well as two leaderboards for groups and individuals.

Results from Foldit have been included in a number of scientific publications. Foldit players have been cited collectively as "Foldit players" or "Players, F." in some cases. Individual players have also been listed as authors on at least one paper, and on four related Protein Data Bank depositions. • An August 2010 paper in the journal Nature credited Foldit's 57,000 players with providing useful results that matched or outperformed algorithmically computed solutions, stating "[p]layers working collaboratively develop a rich assortment of new strategies and algorithms; unlike computational approaches, they explore not only conformational space but also the space of possible search strategies". • A November 2011 article in PNAS compared "recipes" developed by Foldit players to Rosetta scripts developed by members of the Baker Lab at the University of Washington. The player-developed "Blue Fuse" recipe compared favorably with the scientists' "Fast Relax" algorithm. • In 2011, Foldit players helped decipher the crystal structure of a retroviral protease from Mason-Pfizer monkey virus (M-PMV), a monkey virus which causes HIV/AIDS-like symptoms, a scientific problem that had been unsolved for 15 years. While the puzzle was available for three weeks, players produced a 3D model of the enzyme in only ten days that is accurate enough for molecular replacement. • In January 2012, Scientific American reported that Foldit gamers achieved the first crowdsourced redesign of a protein, an enzyme that catalysed the Diels–Alder reactions widely used in synthetic chemistry. A team including David Baker in the Center for Game Science at University of Washington in Seattle computationally designed the enzyme from scratch but found its potency needed improvement. Foldit players reengineered the enzyme by adding 13 amino acids, increasing its activity by more than 18 times. • A September 2016 article in Nature Communications detailed a "crystallographic model-building competition between trained crystallographers, undergraduate students, Foldit players and automatic model-building algorithms" in which "a team of Foldit players achieved the most accurate structure" fitting a protein to the results of an X-ray crystallography experiment. • A July 2018 article in Nature Communications reviewed the collaboration between Foldit players and teams in the WeFold consortium in biennial CASP competitions CASP11 and CASP12. • A June 2019 letter in Nature described the analysis of proteins designed by Foldit players. Four player-designed proteins were successfully grown in E. coli and then "solved" via X-ray crystallography. The proteins were added to the Protein Data Bank as 6MRR, 6MRS, 6MSP, and 6NUK. • In November 2019, an article in PLOS Biology reported how Foldit players were able to "build protein structures into crystallographic, high-resolution maps more accurately than expert crystallographers or automated model-building algorithms" using data from cryo EM experiments.

Foldit's toolbox is mainly for the design of protein molecules. The game's creator announced the plan to add, by 2013, the chemical building blocks of organic subcomponents to enable players to design small molecules. The small molecule design system termed Drugit was tested on the Von Hippel-Lindau tumor suppressor (VHL). Results of the VHL experiment were presented in a March 2023 preprint paper and at an August 2023 American Chemical Society conference session.